Reduced adherence after the COVID-19 diagnosis, increased testosterone clearance, and/or changes in sex hormone binding globulin (SHBG) levels induced by the COVID-19 infection could potentially contribute to lower testosterone levels in the TRT group after the COVID-19 diagnosis. The gene discussed is SHBG; the disease is COVID-19.